Jon Moulton, Chairman of Better Capital, was until recently Managing Partner of Alchemy, a UK-based private equity firm, which invested £2.0 billion of equity with an emphasis on dealing with troubled companies.  Alchemy also has a £300m European special opportunities fund investing principally in distressed debt.

He is a Chartered Accountant, a CF and Fellow of the Institute for Turnaround Professionals.  He previously worked with Citicorp Venture Capital in New York and London, Permira and Apax, where he has invested in a large variety of businesses including Life Sciences.  As well as having been a director of numerous companies and was also formerly Chairman of the British Allergy Foundation.

Lord Robert Winston is professor of Fertility Studies at Imperial College School of Medicine, London University, and is a world renowned fertility expert. He heads the Department of Reproductive Medicine at Hammersmith Hospital in London and is recognised for his several BBC television series, including the Human Body, Secret Life of Twins and Superhuman.

As a researcher into human reproduction, Lord Winston helped develop techniques for sterilisation reversal and his research into embryology and genetics is internationally acclaimed. He is the author of many books including Fertility – A Sympathetic Approach (1985); and Making Babies (1996). Created a Life Peer in 1995, he was recently Chair of the House of Lords Select Committee on Science and Technology.

Mary Archer has been chairman of Cambridge University Hospitals NHS Foundation Trust since 2002.  She is also convenor of the UK University Hospitals Chairs Group, a trustee of Addenbrooke’s Charitable Trust and CRAC, and a non-executive director of the Britten Sinfonia. She read Chemistry at St. Anne’s College, Oxford and obtained her PhD in Physical Chemistry from Imperial College, London.  After post-doctoral work at St. Hilda’s College, Oxford and the Royal Institution, London, she moved to Cambridge and for ten years taught chemistry for Newnham and Trinity Colleges. She is President of the UK Solar Energy Society, the Guild of Church Musicians and the Sinfonia of Cambridge.  She is the author of Rupert Brooke and The Old Vicarage, Grantchester (1989), and co-editor of Clean Electricity from Photovoltaics (2001), Molecular to Global Photosynthesis (2004), Nanostructured and Photoelectrochemical Systems for Solar Photon Conversion (2008) and The 1702 Chair of Chemistry at Cambridge (2005).  In June 2002, she was awarded the Melchett Medal by the Energy Institute, and in 2007 the Eva Philbin Award of the Institute of Chemistry of Ireland.

Nick Ross is a broadcaster who specialises in factual programmes from news and politics to consumer affairs and debates but is best-known for Crimewatch with he fronted for over 23 years. He is a psychologist by background, a Trustee of Sense About Science and a former member of the Committee on the Understanding of Science and twice Chairman of the Science Book Prize. He is President of HealthWatch, a charity devoted to promoting evidence-based medicine and health policy, and for 20 years has championed scientific methodology in many areas of social policy.

He is a member of several national bioethics committees and inquiries, was a Trustee of the Health Quality Service and has served on numerous government advisory boards including the Gene Therapy Advisory Committee. He founded the Jill Dando Institute of Crime Science at University College London where he is an honorary fellow and visiting professor, has an honorary doctorate from Queen's University Belfast and is a Fellow of the Royal Society of Medicine.

Professor Jones is a Director of Allergan Inc. (USA) and Sigma Tau S.p.A (Italy). He is Chairman of the UK stem cell biotech company ReNeuron plc., the International CRO Synexus Ltd., a member of the Boards of NextPharma Technologies Ltd., SciClone Pharmaceuticals Inc. (USA), VeronaPharma plc. and Tecnogen S.p.A. He is a visiting professor at King's College, London and holds honorary degrees and Gold Medals from 6 universities.

From 1987-94, he was a main board director of The Wellcome Foundation, where he was responsible for R&D including the development of AZT, Zovirax, Lamictal, Malarone and other medicines. He is a founder member of the Geneva-based Public: Private Partnership, Medicines for Malaria Venture (MMV), and in 2004 was appointed to the World Health Organisation (WHO) Commission on Intellectual Property Rights, Innovation and Public Health (C.I.P.I.H). He was for 12 years a member of The UK Government regulatory agency The Medicines Commission. For 10 years, until September 2004, he was Director General of the Association of the British Pharmaceutical Industry (ABPI) a member of Council of IFPMA and the Board of EFPIA.

In 2005 he was the winner of the SCRIP Life Time Achievement award for his contribution to the pharmaceutical sciences and industry.

He was honoured by Her Majesty Queen Elizabeth II by the award of CBE in the 2003 New Year's Honours List.

Steve Jones is Professor of Genetics at University College London, President of the Galton Institute, a Trustee of the Charles Darwin Foundation and a board member of the Learning Centre London. He was awarded the Royal Society Faraday Medal for the Public Understanding of Science in 1997.

Professor Jones is particularly concerned with school and public education and has written several books including The Cambridge Encyclopaedia of Human Evolution 1992; Y:The Descent of Men, 2002 and most recently The Single Helix: a Turn around the World of Science, 2005. He gave the 1991 Reith Lectures on ‘The Language of Genes’, presented the BBC TV series ‘In the Blood’ and has a regular column about science matters in the Daily Telegraph.